Ivermectin for the Treatment of Wuchereria bancrofti Filariasis: Efficacy and Adverse Reactions

Kumaraswami, V and Ottesen, E A and Vijayasekaran, D and Uma Devi, S and Swaminathan, S and Aziz, Mohammed A and Raghupati Sarma, G and Prabhakar, R and Tripathy, S P (1988) Ivermectin for the Treatment of Wuchereria bancrofti Filariasis: Efficacy and Adverse Reactions. Journal of the American Medical Association, 259 (21). pp. 3150-3153. ISSN P: 0098-7484; E: 1538-3598

[thumbnail of 198804.pdf] PDF
198804.pdf - Published Version
Restricted to Registered users only

Download (54kB) | Request a copy

Abstract

South India who had microfilaremia and bancroftian filariasis. lvermectin was administered once orally at four dose levels (range, 25 to 200 μg/kg), and at each it was found to be completely effective in clearing blood microfilariae within five to 12 days. In most patients, microfilariae reappeared by three months; by six months the levels averaged 14% to 32% of pretreatment values in the four study groups, and all groups showed equivalent efficacy. Detailed monitoring identified some side effects in almost all patients: usually fever, headache, lightheadedness, myalgia, sore throat, or cough that occurred most prominently 18 to 36 hours after treatment. These were most frequent and severe in patients with the greatest microfilaremia, but only when treated with the two higher doses of ivermectin (100 and 200 μg/kg). The low-dose (25 μg/kg) ivermectin group, despite equivalent efficacy in parasite killing, had clinical reaction scores that were minimal and that were not correlated with parasitemia. Since efficacy and side effects of ivermectin therapy compare favorably with those reported for treatment with the standard antifilarial drug diethylcarbamazine citrate, the major advantage of single-oral-dose administration makes ivermectin the best candidate to replace diethylcarbamazine as the treatment of choice for bancroftian filariasis.

Item Type: Article
Subjects: Tuberculosis > Clinical Research
Filariasis
Divisions: Clinical Research
Depositing User: Dr. Rathinasabapati R
Date Deposited: 22 Aug 2013 07:08
Last Modified: 15 Mar 2016 05:54
URI: http://eprints.nirt.res.in/id/eprint/235

Actions (login required)

View Item View Item